Pure Global
NCT05944640

Dynamic Parameters of Glucose Control in Relation to Biomarkers in Serum and Intraocular Fluid in Patients With Diabetes

Dynamic Parameters of Glucose Control in Relation to Biomarkers in Serum and Intraocular Fluid in Diabetic Patients With Ocular Complications
Charles University, Czech Republic·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Complications
Drug/Device/Intervention
Intraocular surgery
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Charles University, Czech Republic
Location
Prague, Czech
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2022
End date
Jun 01, 2026
Enrollment
213 participants
Primary outcome

miRNA,TIR

Summary

Our project investigates the new characteristics of diabetic retinopathy using liquid eye
 biopsy in combination with novel parameters of glucose control obtained with continuous
 glucose monitoring. This approach will bring new knowledge and implications for future
 therapies.

ICD-10 classifications
Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05944640
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05944640 through Pure Global AI's free database. This phase not specified trial is sponsored by Charles University, Czech Republic and is currently Recruiting. The study focuses on Diabetes Complications. Target enrollment is 213 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.